Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

about

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

Item

http://www.wikidata.org/entity/Q36354086

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

@ast

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

@en

type

Item

label

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

@ast

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

@en

prefLabel

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

@ast

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

@en

P1476

Therapeutic drug monitoring of mitotane: Analytical assay and patient follow-up.

@en

P2093

Claire Gozalo

http://www.w3.org/2001/XMLSchema#string

Damien Vautier

http://www.w3.org/2001/XMLSchema#string

Helene Guillemin

http://www.w3.org/2001/XMLSchema#string

Hervé Millart

http://www.w3.org/2001/XMLSchema#string

Olivier Oget

http://www.w3.org/2001/XMLSchema#string

Zoubir Djerada

http://www.w3.org/2001/XMLSchema#string

P2860

Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.

Simultaneous analysis of mitotane and its main metabolites in human blood and urine samples by SPE-HPLC technique.

Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma.

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment.

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly.

Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results.

A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients.

A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients

P31

scholarly article

P356

10.1002/BMC.3993

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoann Cazaubon

Catherine Feliu

P577

2017-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28432798

http://www.w3.org/2001/XMLSchema#string